Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer.
Kwon M, Kim G, Kim R, Kim KT, Kim ST, Smith S, Mortimer PGS, Hong JY, Loembé AB, Irurzun-Arana I, Koulai L, Kim KM, Kang WK, Dean E, Park WY, Lee J.
Kwon M, et al.
J Immunother Cancer. 2022 Jul;10(7):e005041. doi: 10.1136/jitc-2022-005041.
J Immunother Cancer. 2022.
PMID: 35790315
Free PMC article.
Clinical Trial.